Syra Health Corp. Cl A (SYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,253 | 1,970 | 1,752 | 1,766 | 1,581 |
| Cost of Goods | 1,585 | 1,620 | 1,573 | 1,184 | 1,027 |
| Gross Profit | 668 | 350 | 179 | 582 | 555 |
| Operating Expenses | 1,682 | 2,360 | 2,196 | 1,752 | 924 |
| Operating Income | -429 | -1,390 | -1,444 | -986 | -343 |
| Interest Expense | 2 | 4 | 4 | 9 | 14 |
| Other Income | 14 | 4 | 1 | 0 | 3 |
| Pre-tax Income | -418 | -1,390 | -1,447 | -995 | -354 |
| Net Income Continuous | -418 | -1,390 | -1,447 | -995 | -354 |
| Net Income | $-418 | $-1,390 | $-1,447 | $-995 | $-354 |
| EPS Basic Total Ops | -0.06 | -0.21 | -0.22 | -0.16 | -0.08 |
| EPS Basic Continuous Ops | -0.06 | -0.21 | -0.22 | -0.16 | -0.08 |
| EPS Diluted Total Ops | -0.06 | -0.21 | -0.22 | -0.16 | -0.08 |
| EPS Diluted Continuous Ops | -0.06 | -0.21 | -0.22 | -0.16 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.21 | -0.22 | -0.16 | -0.08 |
| EBITDA(a) | $-403 | $-1,373 | $-1,431 | $-974 | $-331 |